Gulf Pharmaceutical Industries P.S.C. (ADX:JULPHAR)

ADX:JULPHAR Balance Sheet

Financials in millions AED. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	462.6	147.3	204.8	92.3	159.3	73.7
Trading Asset Securities	21.3	21.3	20.5	19.5	19.5	19.7
Cash & Short-Term Investments	483.9	168.6	225.3	111.8	178.8	93.4
Cash Growth	97.43%	-25.17%	101.52%	-37.47%	91.44%	15.45%
Accounts Receivable	675.3	516.6	529	550.4	473.2	647.7
Other Receivables	-	368.6	31.9	34.8	110.9	-
Receivables	675.3	885.2	560.9	585.2	584.1	647.7
Inventory	405.9	413.7	661.7	672.8	653.9	294.3
Prepaid Expenses	-	14.1	14.8	16.2	9.5	-
Restricted Cash	36	76.2	36	-	-	-
Other Current Assets	28	474.2	82.6	76.7	73.3	103.2
Total Current Assets	1,629	2,032	1,581	1,463	1,500	1,139
Property, Plant & Equipment	311.3	314	709.1	752.3	749	901.3
Long-Term Investments	0.2	12.9	18.9	25.5	-	270.6
Other Intangible Assets	81.2	81.3	143.8	158.3	177.2	15
Long-Term Deferred Tax Assets	0.8	0.8	0.8	0.6	0.5	1.8
Total Assets	2,031	2,441	2,454	2,399	2,426	2,327
Accounts Payable	376.5	146.5	207.3	265.9	275.3	338.5
Accrued Expenses	-	108.2	105.9	114.9	154.6	-
Short-Term Debt	-	148.1	125.4	20.5	54.4	156.8
Current Portion of Long-Term Debt	101	152.5	90	37.5	-	234.1
Current Portion of Leases	16.4	49.4	38.6	39.2	31.9	-
Current Income Taxes Payable	31.7	5.2	7.7	5.9	5.9	-
Current Unearned Revenue	-	1.6	1.5	1.5	8.5	207
Other Current Liabilities	3.5	314.3	122.7	113.1	115.3	37
Total Current Liabilities	529.1	925.8	699.1	598.5	645.9	973.4
Long-Term Debt	428.9	612.5	765	712.5	665	220.9
Long-Term Leases	42.4	8.5	91.6	76	67.8	-
Long-Term Deferred Tax Liabilities	7.6	8.3	8	3.3	4	3.7
Total Liabilities	1,083	1,631	1,648	1,471	1,463	1,257
Common Stock	1,155	1,155	1,155	1,155	1,155	1,155
Retained Earnings	21.4	-119.5	-161.2	-65.8	-36.4	-107.7
Comprehensive Income & Other	-239	-236.7	-199.9	-173	-162.2	-146.5
Total Common Equity	937.7	799.1	794.2	916.5	956.7	901.1
Minority Interest	11	10.5	12	11.7	7.1	168.8
Shareholders' Equity	948.7	809.6	806.2	928.2	963.8	1,070
Total Liabilities & Equity	2,031	2,441	2,454	2,399	2,426	2,327
Total Debt	588.7	971	1,111	885.7	819.1	611.8
Net Cash (Debt)	-104.8	-802.4	-885.3	-773.9	-640.3	-518.4
Net Cash Per Share	-0.09	-0.69	-0.77	-0.67	-0.55	-0.49
Filing Date Shares Outstanding	1,155	1,155	1,155	1,155	1,155	1,155
Total Common Shares Outstanding	1,155	1,155	1,155	1,155	1,155	1,155
Working Capital	1,100	1,106	882.2	864.2	853.7	165.2
Book Value Per Share	0.81	0.69	0.69	0.79	0.83	0.78
Tangible Book Value	856.5	717.8	650.4	758.2	779.5	886.1
Tangible Book Value Per Share	0.74	0.62	0.56	0.66	0.67	0.77
Land	-	3.7	3.7	3.7	3.7	43.9
Buildings	-	368.2	508.1	508.1	505.6	623.9
Machinery	-	875.7	1,357	1,323	1,282	1,356
Construction In Progress	-	35.6	14.2	31.4	20.3	3.8
Leasehold Improvements	-	18.5	22.2	19.7	13.5	9.3

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.